Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

26.71 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 111,040
Open 26.71
Bid (Size) 26.60 (1)
Ask (Size) 26.62 (6)
Prev. Close 26.71
Today's Range 26.71 - 26.71
52wk Range 11.20 - 72.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Reasons to Like HIMS and 1 to Stay Skeptical
Since April 2020, the S&P 500 has delivered a total return of 92.9%. But one standout stock has nearly doubled the market - over the past five years, Hims & Hers Health has surged 172% to $26.89 per... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Is the Market Bullish or Bearish on Hims & Hers Health?
Via Benzinga

Performance

YTD
+5.99%
+5.99%
1 Month
-28.60%
-28.60%
3 Month
-10.13%
-10.13%
6 Month
+24.93%
+24.93%
1 Year
+116.63%
+116.63%

More News

Read More
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
Via The Motley Fool
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Via StockStory
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Exposures Economy Interest Rates Political
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
From Hims & Hers
Via Business Wire
Hims’ Weight Loss Expansion: Real Growth or Just Hype?
Via MarketBeat
Exposures Product Safety
Exploring the Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS) as It Nears a Breakout.
Via Chartmill
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know
Via StockStory
Topics Artificial Intelligence Government World Trade
Exposures Artificial Intelligence Political Tariff
Why Hims & Hers Health Stock Couldn't Beat the Market Today
Via The Motley Fool
What's Driving the Market Sentiment Around Hims & Hers Health?
Via Benzinga
Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
Via Investor's Business Daily
nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Newsmax, Waton Financial, Johnson & Johnson, Hims & Hers Health, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Hims & Hers Adds Eli Lilly's Zepbound To Weight-Loss Offerings: Retail Excited Despite BofA Seeing 'Immaterial' Sales Impact
Via Stocktwits
Why Hims & Hers Health Stock Soared Tuesday
Via The Motley Fool
Topics Stocks
Exposures US Equities
Hims & Hers Health Stock Jumped Tuesday Afternoon: What Happened?
Via Benzinga
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Product Safety Supply Chain
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound
Via Investor's Business Daily
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
Via MarketBeat
1 Stock Under $50 on Our Watchlist and 2 to Turn Down
Via StockStory
Is Hims & Hers Stock Too Cheap to Pass Up?
Via The Motley Fool
Smart Money Is Betting Big In HIMS Options
Via Benzinga
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Via The Motley Fool
Topics Earnings
Exposures Financial Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.